Yafei Biology has completed the B2 round of financing of over 400 million yuan.

Yafei (Shanghai) Biomedical Technology Co., Ltd. announced that the company has completed the B2 round of financing, with an investment of more than 400 million yuan in this round. This round of financing is led by SDIC Investment and Merchants Capital, and jointly participated by investment institutions such as China Growth Capital, Hongcheng Investment, Guozheng Investment, Guosheng Capital, Hongfu Assets, Ansheng Guosheng Microchip Fund, Guoyuan Innovation Investment, and Hongyao Kechuang. (Jiemian)